The results of this study suggest that prediction based on the radiomic characteristics of MRI could noninvasively predict the expression of PD-L2 in HCC before surgery and provide a reference for the selection of immune checkpoint blockade therapy. This evidence concerns the gene PDCD1LG2 and hepatocellular carcinoma.